Structure Database (LMSD)
LMSD: Lipid classification search results
Prenol Lipids [PR] (W) --> Isoprenoids [PR01]--> C30 isoprenoids (triterpenes) [PR0106]| LM_ID | Common Name | Systematic Name | Species Shorthand | Formula | Mass |
|---|---|---|---|---|---|
| LMPR01060032 | - | 25-O-methyl-12β, 20S-dihydroxydammar- 23-en-3-one | - | C31H52O4 | 488.3866 |
| LMPR01060033 | - | 12β, 20S,24R-trihydroxydammar-25-en-3- one | - | C30H50O4 | 474.3709 |
| LMPR01060034 | - | 12β, 20S,-trihydroxydammar-23-en-3,25- dione | - | C29H46O4 | 458.3396 |
| LMPR01060035 | - | 12β,20S,-trihydroxydammar-3,25-dione | - | C29H48O4 | 460.3553 |
| LMPR01060036 | 3-O-α-L-arabinosyl oleanolic acid | 3β-O-α-L-arabinosyl hydroxyolean-12- en-28-oic acid | - | C35H56O7 | 588.4026 |
| LMPR0106010002 | Squalene (W) | Squalene | - | C30H50 | 410.3913 |
| LMPR0106010003 | Presqualene diphosphate | Presqualene diphosphate | - | C30H52O7P2 | 586.3188 |
| LMPR0106010004 | Tetrahydrosqualene | Tetrahydrosqualene | - | C30H54 | 414.4226 |
| LMPR0106010005 | C30:6 Highly branched isoprenoid A | 2,6,10,14,18-pentamethyl-13E-(3-methyl- pent-4-enylidene)-nonadeca-2,6E,10Z,17- tetraene | - | C30H50 | 410.3913 |
| LMPR0106010006 | C30:6 Highly branched isoprenoid B | 2,6,10,14,18-pentamethyl-13E-(3-methyl- pent-4-enylidene)-nonadeca-2,6E,10E,17- tetraene | - | C30H50 | 410.3913 |
| LMPR0106010007 | C30:5 Monocyclic highly branched isoprenoid B | 2,6,10,14,18-pentamethyl-13E-(3-methyl- pent-4-enylidene)-nonadeca-2,6E,10E- triene | - | C30H52 | 412.4069 |
| LMPR0106010008 | C30:5 Highly branched isoprenoid | 2,6,10,14,18-pentamethyl-13E-(3-methyl- pent-4-enylidene)-nonadeca-2,6E,10Z- triene | - | C30H52 | 412.4069 |
| LMPR0106010009 | C30 Highly branched isoprenoid | 2,6,10,14,18-pentamethyl-7-(3-methyl- pentyl)-nonadecane | - | C30H62 | 422.4851 |
| LMPR0106010010 | 3S-squalene-2,3-epoxide | 2,3S-epoxy-2,6,10,15,19,23- hexamethyltetracosa-6E,10E,14E,18E,22- pentaene | - | C30H50O | 426.3862 |
| LMPR0106010032 | 2-hydroperoxy-squalene | 2-hydroperoxy-2,6,10,15,19,23- hexamethyltetracosa-3E,6E,10E,14E,18E, 22-hexaene | - | C30H50O2 | 442.3811 |
| LMPR0106010033 | 11-hydroperoxy-squalene | 11-hydroperoxy-10-methylene-2,6,15,19, 23-pentamethyltetracosa-2,6E,14E,18E, 22-pentaene | - | C30H50O2 | 442.3811 |
| LMPR0106010034 | 3-hydroperoxy-squalene | 3-hydroperoxy-2,6,10,15,19,23- hexamethyltetracosa-1,6E,10E,14E,18E, 22-hexaene | - | C30H50O2 | 442.3811 |
| LMPR0106010035 | 6-hydroperoxy-squalene | 6-hydroperoxy-2,6,10,15,19,23- hexamethyltetracosa-2,7E,10E,14E,18E, 22-hexaene | - | C30H50O2 | 442.3811 |
| LMPR0106010036 | 7-hydroperoxy-squalene | 7-hydroperoxy-6-methylene-2,10,15,19, 23-pentamethyltetracosa-2,10E,14E,18E, 22-pentaene | - | C30H50O2 | 442.3811 |
| LMPR0106010037 | 10-hydroperoxy-squalene | 10-hydroperoxy-2,6,10,15,19,23- hexamethyltetracosa-2,6E,11E,14E,18E, 22-hexaene | - | C30H50O2 | 442.3811 |
| LMPR0106010038 | Diepoxysqualene | 2,3S:22S,23-diepoxysqualene | - | C30H50O2 | 442.3811 |
| LMPR0106010039 | Squalen-1-ol | Squalen-1-ol | - | C30H50O | 426.3862 |
| LMPR0106020001 | C30:5 Monocyclic highly branched isoprenoid A | 1-methyl-4-(prop-1-en-2-yl)-3-(3,7,11, 15-tetramethyl-hexadeca-1,10E,14-trien- 7-yl)-cyclohex-1-ene | - | C30H50 | 410.3913 |
| LMPR0106020002 | C30:4 Monocyclic highly branched isoprenoid | 1-methyl-4-(prop-1-en-2-yl)-3-(3,7,11, 15-tetramethyl-hexadeca-1,10E-dien-7- yl)-cyclohex-1-ene | - | C30H52 | 412.4069 |
| LMPR0106020003 | C30 Monocyclic highly branched isoprenoid | 1-isopropyl-4-methyl-2-(3,7,11,15- tetramethyl-hexadecan-7-yl)-cyclohexane | - | C30H60 | 420.4695 |
| LMPR0106030001 | Botryococcane | 10-ethyl-2,6,10,13,17,21-hexamethyl- docosane | - | C30H62 | 422.4851 |
| LMPR0106030002 | Penta-unsaturated monocyclic botrycoccane | - | - | C34H58 | 466.4538 |
| LMPR0106030003 | Monocyclic botryococcane | - | - | C34H68 | 476.5321 |
| LMPR0106030004 | Botryococcene (W) | 2,3S,7S,10S,13R,16S,20S,21-octamethyl- 6,17-dimethylene-10-vinyldocosa-1,11E, 21-triene | - | C34H58 | 466.4538 |
| LMPR0106040001 | (-)-Fusidic acid (W) | (-)-16β-acetoxy-3α,11α- dihydroxyfusida-17(20)Z,24-diene-21- oic acid | - | C31H48O6 | 516.3451 |
| LMPR0106040002 | (-)-Helvolic acid | (-)-6β,16β-diacetoxy-3,7-dioxofusida- 17(20)Z,24-diene-21-oic acid | - | C34H48O7 | 568.3400 |
| LMPR0106050003 | Applanoic acid E | (17S,25S)-7β,8β-epoxy-3,12,15,20,23- pentaoxo-22(20-17)-abeo-lanosta-9(11)- en-26-oic acid | - | C30H38O8 | 526.2567 |
| LMPR0106050004 | Applanoic acid F | (17S,25S)-7-hydroxy-3,12,15,20,23- pentaoxo-22(20-17)-abeo-lanosta-7,9(11) -dien-26-oic acid | - | C30H38O8 | 526.2567 |
| LMPR0106050005 | Ganodermanontriol | 3-oxo-lanosta-7,9(11)-dien-24S,25R,26- triol | - | C30H48O4 | 472.3553 |
| LMPR0106050006 | 24R,25S-Ganodermanontriol | 3-oxo-lanosta-7,9(11)-dien-24R,25S,26- triol | - | C30H48O4 | 472.3553 |
| LMPR0106050007 | Ganocasurarin A | 3-oxo-14-demethyl-lanosta-8(14),24- dien-15α-methyl-7α,9α,15β,26-tetraol | - | C30H48O5 | 488.3502 |
| LMPR0106050008 | Ganocasurarin B | 14-demethyl-lanosta-8(14),24-dien-15α- methyl-3β,7α,9α,15β,26-pentaol | - | C30H50O5 | 490.3658 |
| LMPR0106080001 | (+)-24-Dammarene-3β-20S-diol | - | - | C30H52O2 | 444.3967 |
| LMPR0106080002 | (+)-24-Dammarene-3α,12β,20S-triol | - | - | C30H52O3 | 460.3916 |
| LMPR0106080003 | Protopanaxadiol (W) | 24-Dammarene-3β,12β-20S-triol | - | C30H52O3 | 460.3916 |
| LMPR0106080005 | Helvolic acid | (4α,6β,8α,9β,13α,14β,16β,17β)-6, 16- bis(acetyloxy)-3,7-dioxo-29- nordammara-1,17(20),24-trien-21-oic acid | - | C33H44O8 | 568.3036 |
| LMPR0106080006 | Gypenoside S1 | 3β,20S,21-trihydroxy-25-methoxydammar- 23-ene-12-one-3-O-{[α-l- rhamnopyranosyl(1-2)]-[β-d- glucopyranosyl-(1-3)]-α-l- arabinopyranosyl}-21-O-β-d- glucopyranoside | - | C54H90O23 | 1106.5873 |
| LMPR0106080007 | Gypenoside S2 | 3β,20S,21-trihydroxy-25-methoxydammar- 23-ene-12-one-3-O-{[α-l- rhamnopyranosyl(1-2)]-[β-d- xylopyranosyl(1-3)]-α-l- arabinopyranosyl}-21-O-β-d- glucopyranoside | - | C53H88O22 | 1076.5767 |
| LMPR0106080008 | Gypenoside S3 | 19-oxo-3β,20S,21-trihydroxy-25- methoxydammar-23-ene-3-O-{[α-l- rhamnopyranosyl(1-2)]-[β-d- xylopyranosyl(1-3)]-α-l- arabinopyranosyl}-21-O-β-d- glucopyranoside | - | C53H88O22 | 1076.5767 |
| LMPR0106080009 | Gypenoside S4 | 19-oxo-3β,20S,21,25-tetrahydroxy-23- ene-3-O-{[α-l-rhamnopyranosyl(1-2)]- [β-d-xylopyranosyl(1-3)]-α-l- arabinopyranosyl}-21-O-β-d- glucopyranoside | - | C52H86O22 | 1062.5611 |
| LMPR0106080010 | Ginsenoside Rg3 | 12β,20S-dihydroxydammar-24-en-3β-yl 2-O-βD-glucopyranosyl-β-D- glucopyranoside | - | C42H72O13 | 784.4973 |
| LMPR0106080011 | Ginsenoside Rg1 | 3β,12β-dihydroxydammar-24-ene-6α,20- diyl bis-β-D-glucopyranoside | - | C42H72O14 | 800.4922 |
| LMPR0106080012 | Ginsenoside Rg2 | (6α)-3β,12β,20-trihydroxydammar-24- en-6-yl 2-O-(α-L-rhamnopyranosyl)-β-D- glucopyranoside | - | C42H72O13 | 784.4973 |
| LMPR0106080013 | Ginsenoside Rb1 | 20-[(6-O-β-D-glucopyranosyl-β-D- glucopyranosyl)oxy]-12β-hydroxydammar- 24-en-3β-yl 2-O-β-D-glucopyranosyl- β-D-glucopyranoside | - | C54H92O23 | 1108.6029 |
| LMPR0106080014 | Ginsenoside Rd | 20-(β-D-glucopyranosyloxy)-12β- hydroxydammar-24-en-3β-yl 2-O-β-D- glucopyranosyl-β-D-glucopyranoside | - | C48H82O18 | 946.5501 |